리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2024년 09월
페이지 정보:영문 283 Pages
라이선스 & 가격 (부가세 별도)
한글목차
외측 상과염 치료 세계 시장은 2030년까지 112억 달러에 달할 것으로 예상
2023년 95억 달러로 추정되는 세계 외측 상과염 치료 시장은 2030년에는 112억 달러에 달할 것으로 예상되며, 2023-2030년의 분석 기간 동안 2.5%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다. 본 보고서에서 분석한 부문 중 하나인 비수술적 치료는 CAGR 2.9%를 기록하여 분석 기간 종료 시점에 74억 달러에 도달할 것으로 예상됩니다. 외과적 치료 분야의 성장률은 분석 기간 동안 CAGR 1.6%로 추정됩니다.
미국 시장 26억 달러로 추정, 중국은 CAGR 5.0%로 성장 전망
미국의 외측 상과염 치료 시장은 2023년 26억 달러에 달할 것으로 추정됩니다. 세계 2위의 경제 대국인 중국은 2030년까지 22억 달러 규모에 도달할 것으로 예상되며, 2023-2030년의 분석 기간 동안 5.0%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 0.6%와 1.8%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다. 유럽에서는 독일이 연평균 1.2%의 성장률을 보일 것으로 예상됩니다.
세계 외측 상과염 치료제 시장 - 주요 동향 및 촉진요인 정리
외측 상과염이란 무엇이며, 왜 효과적인 치료가 중요한가?
일반적으로 테니스 엘보로 알려진 외측 상과염은 팔꿈치 외측 상과에 부착 된 힘줄의 염증과 미세 파열로 인한 고통스러운 질병입니다. 이 질환은 일반적으로 팔뚝 근육의 반복적 인 스트레스와 과도한 사용으로 인해 팔꿈치 바깥쪽에 통증과 압통을 유발합니다. 외상과염은 운동선수, 특히 테니스 선수에게 많이 발생하지만 도장공, 목수, 사무직 종사자 등 손목과 팔을 반복적으로 사용하는 사람이라면 누구나 발병할 수 있습니다. 이 증상은 일상 생활과 업무 관련 작업을 수행하는 능력에 큰 영향을 미칠 수 있기 때문에 효과적인 치료가 매우 중요합니다. 외측 상과염을 치료하지 않고 방치하면 만성적인 통증과 신체적 장애로 이어질 수 있어 조기 개입의 중요성이 강조되고 있습니다. 이 증상의 근본 원인과 메커니즘을 이해하는 것은 증상을 완화 할뿐만 아니라 문제의 근본 원인을 해결하는 효과적인 치료 전략을 개발하는 데 필수적입니다.
외측 상과염의 현재 치료법은?
외측 상과염의 치료는 통증 완화, 치유 촉진, 기능 회복을 목표로 하는 다양한 접근법을 조합하여 시행합니다. 보존적 치료는 일반적으로 휴식, 얼음찜질, 비스테로이드성 항염증제(NSAIDs)로 통증과 염증을 조절하는 보존적 치료가 우선적으로 시행됩니다. 물리치료는 치료에 중요한 역할을 하며, 팔뚝 근육의 스트레칭과 강화 운동에 중점을 두어 환부의 힘줄에 가해지는 부담을 줄입니다. 긴장 상태에서 근육을 스트레칭하는 편심 운동은 힘줄의 치유를 촉진하는 데 특히 효과적인 것으로 나타났습니다. 또한 손목 부목이나 카운터 포스 브레이스와 같은 보조기는 활동 중 부담을 줄이기 위해 종종 사용됩니다. 보존적 치료에 반응하지 않는 환자에게는 부신피질 스테로이드 주사, 다혈소판 혈장(PRP) 요법, 충격파 치료와 같은 고급 치료가 고려됩니다. 이러한 치료는 염증을 억제하고 힘줄 수준에서 조직 회복을 촉진하는 것을 목표로 합니다. 드물게 보존적 치료나 최소침습적 치료가 실패한 경우, 힘줄 이완 및 수복과 같은 수술적 치료가 필요할 수 있습니다. 치료 방법의 선택은 병의 중증도, 환자의 희망, 초기 치료에 대한 반응에 따라 결정됩니다.
외측 상과염의 치료는 어떻게 발전하고 있는가?
의료기술의 혁신과 지속적인 연구로 인해 외측상과염의 치료 옵션은 지속적으로 발전하고 있으며, 난치성 및 중증 환자들에게 새로운 희망을 가져다주고 있습니다. 가장 유망한 연구 분야 중 하나는 재생의학, 특히 다혈소판 혈장(PRP) 요법으로, 환자 자신의 혈소판을 농축하여 환부에 주입하여 성장 인자를 방출하여 치유를 촉진하는 PRP 요법입니다. 이 치료는 특히 다른 치료법에 반응하지 않는 만성 환자에서 통증을 줄이고 기능을 개선하는 유망한 결과를 보여주고 있습니다. 또 다른 혁신 분야는 체외 충격파 치료(ESWT)의 개발로, ESWT는 음파를 사용하여 혈류를 자극하고 힘줄 부위의 조직 회복을 촉진하는 치료법입니다. 연구 결과, ESWT는 만성 외측 상과염의 효과적인 치료법이자 수술의 대안이 될 수 있다는 것이 입증되었습니다. 또한, 웨어러블 기술의 발전으로 재활 운동 중 근육 활동과 긴장에 대한 실시간 피드백을 제공함으로써 외측 상과염의 관리를 강화할 수 있게 되었습니다. 이러한 기술 혁신은 치료 효과를 향상시킬 뿐만 아니라 회복 시간을 단축하고 재발 위험을 최소화할 수 있습니다.
외측 상과염 치료 시장의 성장을 가속하는 요인은 무엇인가?
외측 상과염 치료 시장의 성장은 기술 발전, 환자층의 변화, 의료 관행의 진화를 반영하는 몇 가지 요인에 의해 주도되고 있습니다. 주요 요인 중 하나는 인구의 고령화와 다양한 직업에서 반복적 인 부하 손상 발생률이 증가함에 따라 외측 상과염을 포함한 근골격계 질환의 유병률이 증가하고 있으며, PRP 요법 및 ESWT와 같은 최소 침습적 치료법의 개발과 같은 기술 발전은 환자가 이용할 수있는 선택의 폭을 넓혀 시장 성장에 기여하고 있습니다. 시장 성장에 기여하고 있습니다. 또한, 개인 맞춤형 의료에 대한 관심이 높아지고 디지털 헬스 툴의 통합으로 외측상과염의 진단과 관리가 강화되어 치료가 더욱 친숙하고 효과적일 수 있게 되었습니다. 의료비 지출 증가와 신흥 시장에서 고급 치료 옵션의 가용성 증가도 시장 확대의 주요 요인으로 작용하고 있습니다. 또한, 환자와 의료진 모두 조기 진단과 조기 개입에 대한 인식이 높아지면서 효과적이고 혁신적인 치료법에 대한 수요가 증가하고 있습니다. 이러한 요인들은 지속적인 연구개발과 함께 외측 상과염 치료 시장의 성장을 견인할 것으로 예상됩니다.
조사 대상 기업 예시(총 52건)
3M Company
Aksigen Hospital Care
Beurer GmbH
BioMedical Life Systems, Inc.
BTL Industries
EMS Physio Ltd.
Johari Digital Healthcare Ltd.
OMRON Healthcare Co.
Ossur hf.
Ottobock SE & Co. KGaA
Seikagaku Corporation
Teikoku Pharma USA
Zimmer Biomet Holdings, Inc.
Zynex, Inc.
목차
제1장 조사 방법
제2장 주요 요약
시장 개요
주요 기업
시장 동향과 촉진요인
세계 시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
스페인
러시아
기타 유럽
아시아태평양
호주
인도
한국
기타 아시아태평양
라틴아메리카
아르헨티나
브라질
멕시코
기타 라틴아메리카
중동
이란
이스라엘
사우디아라비아
아랍에미리트(UAE)
기타 중동
아프리카
제4장 경쟁
LSH
영문 목차
영문목차
Global Lateral Epicondylitis Treatment Market to Reach US$11.2 Billion by 2030
The global market for Lateral Epicondylitis Treatment estimated at US$9.5 Billion in the year 2023, is expected to reach US$11.2 Billion by 2030, growing at a CAGR of 2.5% over the analysis period 2023-2030. Non-Surgical Therapies, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$7.4 Billion by the end of the analysis period. Growth in the Surgical Therapies segment is estimated at 1.6% CAGR over the analysis period.
The U.S. Market is Estimated at US$2.6 Billion While China is Forecast to Grow at 5.0% CAGR
The Lateral Epicondylitis Treatment market in the U.S. is estimated at US$2.6 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.2 Billion by the year 2030 trailing a CAGR of 5.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.6% and 1.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.2% CAGR.
Global Lateral Epicondylitis Treatment Market - Key Trends and Drivers Summarized
What Is Lateral Epicondylitis and Why Is Effective Treatment Crucial?
Lateral epicondylitis, commonly known as tennis elbow, is a painful condition resulting from inflammation or microtearing of the tendons that attach to the lateral epicondyle of the elbow. This condition is typically caused by repetitive stress or overuse of the forearm muscles, leading to pain and tenderness on the outer part of the elbow. While it is often associated with athletes, particularly tennis players, lateral epicondylitis can affect anyone who engages in repetitive wrist and arm motions, such as painters, carpenters, or office workers. The condition can significantly impact a person’s ability to perform daily activities and work-related tasks, making effective treatment crucial. Left untreated, lateral epicondylitis can lead to chronic pain and disability, underscoring the importance of early intervention. Understanding the underlying causes and mechanisms of this condition is essential for developing effective treatment strategies that not only alleviate symptoms but also address the root cause of the problem.
What Are the Current Treatment Options for Lateral Epicondylitis?
The treatment of lateral epicondylitis involves a combination of approaches aimed at reducing pain, promoting healing, and restoring function. Conservative treatment is typically the first line of defense, starting with rest, ice application, and nonsteroidal anti-inflammatory drugs (NSAIDs) to manage pain and inflammation. Physical therapy plays a crucial role in treatment, focusing on stretching and strengthening exercises for the forearm muscles to alleviate strain on the affected tendons. Eccentric exercises, where the muscle lengthens under tension, have shown particular efficacy in promoting tendon healing. Additionally, orthotic devices such as wrist splints or counterforce braces are often used to reduce strain during activities. For patients who do not respond to conservative measures, more advanced treatments like corticosteroid injections, platelet-rich plasma (PRP) therapy, or shockwave therapy may be considered. These interventions aim to reduce inflammation or stimulate tissue repair at the tendon level. In rare cases, when conservative and minimally invasive treatments fail, surgical options such as tendon release or repair may be necessary. The choice of treatment depends on the severity of the condition, patient preferences, and the response to initial therapies.
How Are Innovations and Research Advancing the Treatment of Lateral Epicondylitis?
Innovations in medical technology and ongoing research are continuously advancing the treatment options for lateral epicondylitis, offering new hope for patients with persistent or severe cases. One of the most promising areas of research is regenerative medicine, particularly the use of platelet-rich plasma (PRP) therapy. PRP involves injecting a concentrated dose of the patient’s own platelets into the affected area to promote healing through the release of growth factors. This treatment has shown encouraging results in reducing pain and improving function, particularly in chronic cases that have not responded to other therapies. Another area of innovation is the development of extracorporeal shockwave therapy (ESWT), which uses sound waves to stimulate blood flow and promote tissue repair at the tendon site. Research has demonstrated that ESWT can be an effective treatment for chronic lateral epicondylitis, offering an alternative to surgery. Additionally, advancements in wearable technology are enhancing the management of lateral epicondylitis by providing real-time feedback on muscle activity and strain during rehabilitation exercises. These innovations are not only improving the effectiveness of treatment but also reducing recovery times and minimizing the risk of recurrence.
What Factors Are Driving Growth in the Lateral Epicondylitis Treatment Market?
The growth in the lateral epicondylitis treatment market is driven by several factors that reflect technological advancements, changing patient demographics, and evolving healthcare practices. One of the primary drivers is the increasing prevalence of musculoskeletal disorders, including lateral epicondylitis, as a result of aging populations and the rising incidence of repetitive strain injuries in various professions. Technological advancements, such as the development of minimally invasive treatments like PRP therapy and ESWT, have expanded the range of options available to patients and are contributing to the market's growth. Additionally, the growing focus on personalized medicine and the integration of digital health tools are enhancing the diagnosis and management of lateral epicondylitis, making treatments more accessible and effective. The rise in healthcare expenditure and the increasing availability of advanced treatment options in emerging markets are also significant factors fueling market expansion. Furthermore, the emphasis on early diagnosis and intervention, driven by increased awareness among both patients and healthcare providers, is boosting demand for effective and innovative treatments. These factors, combined with ongoing research and development, are expected to continue driving growth in the lateral epicondylitis treatment market.
Select Competitors (Total 52 Featured) -
3M Company
Aksigen Hospital Care
Beurer GmbH
BioMedical Life Systems, Inc.
BTL Industries
EMS Physio Ltd.
Johari Digital Healthcare Ltd.
OMRON Healthcare Co., Ltd.
Ossur hf.
Ottobock SE & Co. KGaA
Seikagaku Corporation
Teikoku Pharma USA
Zimmer Biomet Holdings, Inc.
Zynex, Inc.;
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Lateral Epicondylitis Treatment - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Incidence of Sports-Related Injuries Expands Addressable Market Opportunity for Lateral Epicondylitis Treatments
Advancements in Non-Surgical Therapies Propel Growth in Conservative Treatment Options for Lateral Epicondylitis
Increasing Adoption of Minimally Invasive Procedures Drives Demand for Innovative Lateral Epicondylitis Treatments
Integration of Biologic and Regenerative Medicine Throws the Spotlight on Novel Treatment Modalities for Tendon Repair
Emergence of Wearable and Assistive Technologies Expands Market Scope for Rehabilitation and Prevention of Lateral Epicondylitis
Rising Geriatric Population and Associated Tendon Degeneration Generate Demand for Long-Term Management Solutions
Challenges in Treatment Efficacy and Recurrence Rates Present Opportunities for Innovation in Therapeutic Approaches
Expansion of Sports Medicine Clinics and Physical Therapy Centers Creates New Opportunities for Lateral Epicondylitis Treatment Adoption
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Lateral Epicondylitis Treatment Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 3: World Historic Review for Lateral Epicondylitis Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 4: World 16-Year Perspective for Lateral Epicondylitis Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Non-Surgical Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 6: World Historic Review for Non-Surgical Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 7: World 16-Year Perspective for Non-Surgical Therapies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Surgical Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 9: World Historic Review for Surgical Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 10: World 16-Year Perspective for Surgical Therapies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 12: World Historic Review for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 13: World 16-Year Perspective for Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Pharma & Drug Stores End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 15: World Historic Review for Pharma & Drug Stores End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 16: World 16-Year Perspective for Pharma & Drug Stores End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 17: USA Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 18: USA Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 19: USA 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
TABLE 20: USA Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 21: USA Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 22: USA 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
CANADA
TABLE 23: Canada Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 24: Canada Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 25: Canada 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
TABLE 26: Canada Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 27: Canada Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 28: Canada 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
JAPAN
Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 29: Japan Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 30: Japan Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 31: Japan 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
TABLE 32: Japan Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 33: Japan Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 34: Japan 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
CHINA
Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 35: China Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 36: China Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 37: China 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
TABLE 38: China Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 39: China Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 40: China 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
EUROPE
Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 41: Europe Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 42: Europe Historic Review for Lateral Epicondylitis Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 43: Europe 16-Year Perspective for Lateral Epicondylitis Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 44: Europe Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 45: Europe Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 46: Europe 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
TABLE 47: Europe Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 48: Europe Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 49: Europe 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
FRANCE
Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 50: France Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 51: France Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 52: France 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
TABLE 53: France Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 54: France Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 55: France 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
GERMANY
Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 56: Germany Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 57: Germany Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 58: Germany 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
TABLE 59: Germany Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 60: Germany Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 61: Germany 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
ITALY
TABLE 62: Italy Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 63: Italy Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 64: Italy 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
TABLE 65: Italy Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 66: Italy Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 67: Italy 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
UNITED KINGDOM
Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 68: UK Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 69: UK Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 70: UK 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
TABLE 71: UK Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 72: UK Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 73: UK 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
SPAIN
TABLE 74: Spain Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 75: Spain Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 76: Spain 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
TABLE 77: Spain Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 78: Spain Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 79: Spain 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
RUSSIA
TABLE 80: Russia Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 81: Russia Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 82: Russia 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
TABLE 83: Russia Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 84: Russia Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 85: Russia 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 87: Rest of Europe Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 88: Rest of Europe 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 90: Rest of Europe Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 91: Rest of Europe 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 93: Asia-Pacific Historic Review for Lateral Epicondylitis Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 94: Asia-Pacific 16-Year Perspective for Lateral Epicondylitis Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 96: Asia-Pacific Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 97: Asia-Pacific 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 99: Asia-Pacific Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 100: Asia-Pacific 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
AUSTRALIA
Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
TABLE 101: Australia Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 102: Australia Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 103: Australia 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
TABLE 104: Australia Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 105: Australia Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 106: Australia 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
INDIA
Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
TABLE 107: India Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 108: India Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 109: India 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
TABLE 110: India Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 111: India Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 112: India 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
SOUTH KOREA
TABLE 113: South Korea Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 114: South Korea Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 115: South Korea 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
TABLE 116: South Korea Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 117: South Korea Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 118: South Korea 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
TABLE 119: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 120: Rest of Asia-Pacific Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 121: Rest of Asia-Pacific 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 123: Rest of Asia-Pacific Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
LATIN AMERICA
Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
TABLE 125: Latin America Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 126: Latin America Historic Review for Lateral Epicondylitis Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 127: Latin America 16-Year Perspective for Lateral Epicondylitis Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
TABLE 128: Latin America Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 129: Latin America Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 130: Latin America 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
TABLE 131: Latin America Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 132: Latin America Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 133: Latin America 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
ARGENTINA
TABLE 134: Argentina Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 135: Argentina Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 136: Argentina 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
TABLE 137: Argentina Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 138: Argentina Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 139: Argentina 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
BRAZIL
TABLE 140: Brazil Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 141: Brazil Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 142: Brazil 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
TABLE 143: Brazil Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 144: Brazil Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 145: Brazil 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
MEXICO
TABLE 146: Mexico Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 147: Mexico Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 148: Mexico 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
TABLE 149: Mexico Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 150: Mexico Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 151: Mexico 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
TABLE 152: Rest of Latin America Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 153: Rest of Latin America Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 154: Rest of Latin America 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 156: Rest of Latin America Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 157: Rest of Latin America 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
MIDDLE EAST
Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
TABLE 158: Middle East Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 159: Middle East Historic Review for Lateral Epicondylitis Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 160: Middle East 16-Year Perspective for Lateral Epicondylitis Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
TABLE 161: Middle East Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 162: Middle East Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 163: Middle East 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
TABLE 164: Middle East Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 165: Middle East Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 166: Middle East 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
IRAN
TABLE 167: Iran Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 168: Iran Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 169: Iran 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
TABLE 170: Iran Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 171: Iran Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 172: Iran 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
ISRAEL
TABLE 173: Israel Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 174: Israel Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 175: Israel 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
TABLE 176: Israel Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 177: Israel Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 178: Israel 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
SAUDI ARABIA
TABLE 179: Saudi Arabia Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 180: Saudi Arabia Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 181: Saudi Arabia 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 183: Saudi Arabia Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 184: Saudi Arabia 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
TABLE 185: UAE Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 186: UAE Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 187: UAE 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
TABLE 188: UAE Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 189: UAE Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 190: UAE 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
TABLE 191: Rest of Middle East Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 192: Rest of Middle East Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 193: Rest of Middle East 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 195: Rest of Middle East Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 196: Rest of Middle East 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
AFRICA
Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
TABLE 197: Africa Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 198: Africa Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 199: Africa 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
TABLE 200: Africa Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 201: Africa Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 202: Africa 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030